Efficacy and Safety of iStent in Reducing Intraocular Pressure in Open-angle Glaucoma

Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Study ID
NCT07354009
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 90 Years
Healthy Volunteers
Accepted

Interventions

  • PHACO+PC-IOL+iStent — PROCEDURE
    PHACO+PC-IOL+iStent
  • PHACO+PC-IOL — PROCEDURE
    PHACO+PC-IOL

Study Details

To evaluate the efficacy and safety of istent inject W in reducing intraocular pressure in Chinese adult patients with open-angle glaucoma complicated with cataract.

Key Dates

First listed
Jan 21, 2026
Start date
Oct 7, 2025
Status verified
Oct 2025
Primary completion
Oct 1, 2026
Completion
Oct 1, 2027

Study Design

Enrollment
60 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: PHACO+PC-IOL+iStent
    Cataract extraction combined with intraocular lens implantation + istent imp
  • Sham Comparator: PHACO+PC-IOL
    Cataract extraction combined with intraocular lens implantation

Primary Outcome Measure

intraocular pressure [ Time Frame: Baseline, 1 day, 1 week, 1 month, 3 months, 6 months and 12 months ]

Central Contacts

Find similar trials

Nationwide
Glaucoma trialsOphthalmology trials

Related Studies